Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.2535
-$0.0025-0.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 57.76% | -86.30% | -17.34% | -5.52% | 8.50% |
| Total Depreciation and Amortization | 125.00% | -20.00% | -47.37% | -5.00% | 5.26% |
| Total Amortization of Deferred Charges | -100.00% | -35.99% | -13.24% | -4.87% | -13.00% |
| Total Other Non-Cash Items | -128.22% | 167.47% | 50,700.00% | 100.61% | 79.36% |
| Change in Net Operating Assets | -194.61% | 2,311.89% | -6.79% | -74.52% | 394.30% |
| Cash from Operations | -34.60% | -42.83% | -12.93% | -16.65% | 30.80% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 43.05% | 1,043.14% | 16.44% | 1,379.41% |
| Cash from Investing | -100.00% | 43.05% | 1,043.14% | 16.44% | 435.91% |
| Total Debt Issued | 216.00% | -- | -- | -- | -- |
| Total Debt Repaid | 51.55% | 31.21% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -59.10% | -354.25% | 200.00% | -- | -- |
| Cash from Financing | 2,363.06% | 57.37% | -1,054.25% | 88.04% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 427.24% | 23.34% | 40.31% | 10.06% | 16.09% |